Loading...
Publication: Lopinavir-Ritonavir (LPV/r) for treament of COVID-19: evidence Review of clinical benefits
Parrish, A Gray, A Kredo, T Maartens, G Reubenson, G Cohen, K De Waal, R Blockman, M Nel, J Rees, H
Parrish, A
Gray, A
Kredo, T
Maartens, G
Reubenson, G
Cohen, K
De Waal, R
Blockman, M
Nel, J
Rees, H
Citations
Altmetric:
Abstract
Description
Lopinavir a potent inhibitor of HIV‐1 protease, is used in the treatment of HIV infection in combination with ritonavir
(1).
Date
2020-12-21
Journal Title
Journal ISSN
Volume Title
Publisher
South African National Department of Health
Collections
Research Projects
Organizational Units
Journal Issue
Keywords
Lopinavir-Ritonavir,Treatment of COVID-19,Protease Inhibitors,Drug for COVID-19,Evidence review